BELLEFONTE, PA, August 17, 2023 – For over 16 million Americans grappling with neurological conditions like stroke, Parkinson’s, and paralysis, a groundbreaking solution is on the horizon to lost restore function. Brain computer implants hold the promise of restoring lost function. But they have a major challenge because the human body treats these implants as foreign bodies which triggers a response that limits the implant’s working lifetime. Actuated Medical’s innovative SonoShield™ Defender uses precisely engineered sound waves to help minimize this foreign body response. Early testing demonstrated the promise of the technology to extend implant working lifetime. To enable continued SonoShield Defender development, Actuated Medical, Inc. has been awarded a $2.2 million Fast-track Phase II Small Business Innovative Research (SBIR) project from the National Institutes of Health-National Institute of Mental Health (NIH-NIMH). Actuated plans to unveil the SonoShield Defender at the Neuroscience 2023 Conference, November 11-15, 2023 in Washington, DC.


“Our commitment to advancing medical technology is poised to make a lasting impact on the lives of millions. The SonoShield Defender has the potential to decrease the foreign body response that plagues many implanted medical devices. Commercialization of the technology will enable a future where neurological conditions are met with enhanced solutions that improve quality of life.” Maureen L. Mulvihill, Ph.D., Actuated Medical President, CEO, and Co-Founder expressed her excitement about the immense potential of this technology.